Yorvipath - Palopegteriparatide 420 ug / 1.4mL Injection 1.4 mL

Reference details for licensed healthcare facility review and verification.

Palopegteriparatide NDC Family 73362-0102 Palopegteriparatide 420 ug / 1.4mL

NDC 11	73362-0102-01
Product NDC	73362-0102
Generic Drug Name	Palopegteriparatide
Brand Name	Yorvipath
Manufacturer	Ascendis Pharma, Endocrinology, Inc.
Strength	420 ug / 1.4mL
Dosage Form	Injection
Drug Type	Subcutaneous
Package Quantity	2 Box
Package Description	2 BOX in 1 CARTON (73362-102-01) / 1 SYRINGE in 1 BOX (73362-102-02) / 1 CONTAINER in 1 SYRINGE (73362-102-03) / 1.4 mL in 1 CONTAINER
Active Ingredients	Palopegteriparatide
Marketing Category	NDA

Unless explicitly stated in writing, no direct affiliation, sponsorship, or endorsement by individual product manufacturers with Premium Rx National, LLC should be implied. All brand names, trade names, and trademarks are the property of their respective owners and are presented solely for accurate product identification and informational reference.

Reference only: This listing is designed to assist product identification and quote review for licensed healthcare facilities. It does not imply manufacturer endorsement, sponsorship, or direct purchasing status.

Request a Quote Review

Start a quote review for this exact presentation or send a product-specific inquiry. We can combine multiple items into one response for licensed healthcare buyers.

Quote Requests Drug Search

Instructions

Click "Add to Quote Request" to add this item and open your quote request.
Continue browsing and add additional products from other exact NDC detail pages if needed.
Submit one quote request with your organization details and required quantities.
You can review or submit at any time from Quote Request.

Licensing requirement: Quote and fulfillment of prescription pharmaceutical products require valid state and federal licensure and related documentation, where applicable.

Quote Review Form

NDC snapshot

Palopegteriparatide 420 ug / 1.4mL Injection is tracked under NDC 73362-0102-01 and rolls up into product family 73362-0102. Use this page to confirm the exact presentation before comparing related family pages or starting a quote review.

Package configuration: 2 Box.
Manufacturer: Ascendis Pharma, Endocrinology, Inc..
Dosage form: Injection.
Family size: 1 indexed presentation.

Click a tag to refine the catalog view around this exact presentation.

Official references

Use official labeling and directory references to confirm presentation details while your team reviews the PRN catalog entry and related sourcing paths.

Search DailyMed labelingOpens DailyMed search results.

Yorvipath - Palopegteriparatide 420 ug / 1.4mL Injection 1.4 mL, NDC 73362-0102-01, is a Ascendis Pharma, Endocrinology, Inc. 420 ug / 1.4mL injection presentation packaged as 2 Box.

NDC search formats

Canonical NDC 11: 73362-0102-01
Digits-only NDC 11: 73362010201
Possible 10-digit display formats: 73362-102-01 (7336210201), 73362-0102-1 (7336201021)

Multiple 10-digit display-format aliases can map to the same stored 11-digit billing NDC, so these are shown as search aliases rather than a single asserted package format.

Helpful product links

Search by brand name: Yorvipath
Exact NDC 11: 73362-0102-01
Product family NDC: 73362-0102
VA classification code: HS900
VA classification code description: HORMONES/SYNTHETICS/MODIFIERS,OTHER
CMOP ID: Y0013
VUID: 4043381